Skip to main content
In stock | Targeted Therapy (Antibody)

Tagraxofusp

Oncology Type Hematologic
Drug Class / Mechanism CD123-Directed Diphtheria Toxin Fusion Protein
No Image
Description

Tagraxofusp is classified as a CD123-Directed Diphtheria Toxin Fusion Protein, sourced for use within our Targeted Therapy (Antibody) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Antibody)
Oncology Type Hematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3